CN1130219C - Litholysizing bear gall powder - Google Patents
Litholysizing bear gall powder Download PDFInfo
- Publication number
- CN1130219C CN1130219C CN01128739A CN01128739A CN1130219C CN 1130219 C CN1130219 C CN 1130219C CN 01128739 A CN01128739 A CN 01128739A CN 01128739 A CN01128739 A CN 01128739A CN 1130219 C CN1130219 C CN 1130219C
- Authority
- CN
- China
- Prior art keywords
- radix
- liver
- gallbladder
- rhizoma
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a traditional Chinese medicine for treating calculi of the liver and the gallbladder, which is prepared from 6 to 180 of longhairy antenoron herb, 6 to 15 of artemisia capillaries, 10 to 20 of galli stomachichum corium, 10 to 30 of white paeony root, 3 to 10 of matrimony vine, 10 to 25 of giant knotweed, 6 to 10 of costustoot, 6 to 10 of bitter orange, 6 to 30 of green tangerine peel, 10 to 25 of tangerine peel, 6 to 10 of nutgrass galingale rhizome, 10 to 30 of curcuma, 10 to 15 of mirabilite, 10 to 20 of rhubarb, 10 to 30 of herba pyrrosiae, 5 to 10 of liquorice, 10 to 30 of raw milkvetch root, 6 to 10 of bupleurum root, 6 to 10 of scutellaria, 6 to 15 of pumice pumex, 10 to 15 of raw haw, 6 to 15 of massa medicata fermentata, 6 to 15 of wheat germ, 10 to 60 of Chinese clematis, 3 to 8 of coptis, 10 to 40 of nacre, 10 to 20 of rehmannia root, 5 to 15 of bear gall and 6 to 10 of alum. The traditional Chinese medicine has the efficiency for dispersing stagnated liver qi, relieving qi stagnation, reducing fever, promoting the functions of the gallbladder, nourishing the liver, the gallbladder and yin blood, resolving phlegm and stasis and removing hepatic calculi. The present invention has the advantages of reasonable prescription and proper preparation, and thus, the traditional Chinese medicine has favorable therapeutical effects on cholelithiasis.
Description
Technical field
The present invention relates to-kind with the pharmaceutical product of animals and plants, especially for the Litholysizing bear gall powder of treatment liver and bile stone as raw material.
Background technology
Existing is the dissolved stone medicine of main component with the Chinese herbal medicine, as CN1158740, in its prescription with Radix Gentianae as main component because this medical herbs distributes seldom, make cost higher.
Summary of the invention
Litholysizing bear gall powder of the present invention is made up of the raw material of following weight portion: Herba Lysimachiae 6-180, Herba Artemisiae Scopariae 6-15, Endothelium Corneum Gigeriae Galli 10-20, Radix Paeoniae Alba 10-30, Fructus Lycii 3-10, Rhizoma Polygoni Cuspidati 10-25, Radix Aucklandiae 6-10, Fructus Aurantii 6-10, Pericarpium Citri Reticulatae Viride 6-30, Pericarpium Citri Reticulatae 10-25, Rhizoma Cyperi 6-10, Radix Curcumae 10-30 Natrii Sulfas 10-15, Radix Et Rhizoma Rhei 10-20, Folium Pyrrosiae 10-30, Radix Glycyrrhizae 5-10, Radix Astragali 10-30, Radix Bupleuri 6-10, Radix Scutellariae 6-10, Pumex 6-15 Fructus Crataegi 10-15, Massa Medicata Fermentata 6-15, Fructus Hordei Germinatus 6-15, Radix Clematidis 10-60, Rhizoma Coptidis 3-8, Concha Margaritifera 10-40, Radix Rehmanniae 10-20, Fel Ursi 5-15, Alumen 6-10.
With above component levigation, 100 orders that sieve, encapsulated or make powder, honeyed pill, the watered pill and all can behind mixing, the disinfection by ultraviolet light.
The present invention has the effect of dispersing the stagnated live-QI to relieve the stagnation of QI, clearing heat secreting bile, the cloudy blood of nourishing the liver gallbladder, the stasis of blood of reducing phlegm, the molten hepatolith that disappears, and is used for liver and bile stone, acute and chronic cholecystitis, again fatty liver, gallbladder hydrops, urinary system calculus is had significant curative effect simultaneously.Have no wound, no pain, take medicine conveniently, have no side effect, calculus dissolving and excreting rate height, treat cholelithiasis 67 examples altogether, male's 24 examples, women's 43 examples, age 25-50 year 39 examples, person's 28 examples more than 50 years old, non-evident sympton or only show general indigestion symptom person 43 examples usually, stomachache arranged, feel sick, symptom's 24 examples such as vomiting, all patients are all through the Abdominal B type ultrasonography inspection more than twice or remake X line, CT, cholangiography inspection and make a definite diagnosis.Cure (the calculus image disappears, and symptom and sign disappear) 36 examples (53.73%), effectively (the calculus image dwindles, symptom and sign obviously alleviate) 22 examples (32.84%), invalid (calculus image no change, sx, sign or deposit) 9 examples (13.43%), total effective rate is 83.57%.
Below be the 67 routine clinical research reports of Litholysizing bear gall powder treatment cholelithiasis:
Cholelithiasis is surgical common disease, frequently-occurring disease, it is generally acknowledged and mostly be cholestasis, biliary tract antibacterial and parasitic infection, the cholesterol metabolism imbalance is principal element, the applicant since nineteen ninety-eight, to intend Litholysizing bear gall powder prescription therapeutic cholelithiasis 67 examples certainly, satisfactory effect now is summarized as follows in clinical practice:
1, clinical data
1.1 the patient of 67 routine patients for the special outpatient clinic treatment organized in treatment, male's 24 examples, women's 43 examples, age 25-50 year 39 examples, person's 28 examples more than 50 years old, non-evident sympton or only show general dyspepsia person's 43 examples usually, stomachache arranged, feel sick, symptom's 24 examples such as vomiting, all patients are all through the Abdominal B type ultrasonography inspection more than 2 times or remake X line, CT, gallbladder examination and make a definite diagnosis.
1.2 matched group 42 routine patients compare there was no significant difference from two groups of sexes of patient, age, the course of disease, the state of an illness, cardinal symptom, the professional aspect of treatment through making a definite diagnosis, and have comparability.
2, Therapeutic Method
2.1 the treatment group is made up of 29 pleasant impression Chinese medicines such as Fel Ursi, Natrii Sulfas, Alumen, Herba Artemisiae Scopariae, Radix Astragali, Radix Curcumae, Radix Et Rhizoma Rhei, names to be Litholysizing bear gall powder, drug dose is grasped flexibly according to patient age, body constitution, every day 3 times, and taking medicine after meal, 30 days is 1 course of treatment.
2.2 matched group is obeyed cholagogic and lithagogue tablet 3 times every day, each 5.
3, therapeutic outcome
3.1 criterion of therapeutical effect: adopt the whole nation unified diagnosis and curative effect judging standard, cure: sings and symptoms disappears, and imaging examination (B ultrasonic, PTC, ERCP, biliary tract vein or oral appearance must have wherein 2 kinds of inspection methods) calculus disappears; Produce effects: sings and symptoms alleviates, imaging examination, and calculus has obvious minimizing, reach more than 1/2, or calculus diminishes 1/2 above person; Effectively: sings and symptoms has and alleviates, and the imaging examination calculus reduces or the person of diminishing before the treatment; Invalid: the sings and symptoms no change, the imaging examination calculus does not have the changer.
3.2 two groups of total effectses relatively treatment are organized 67 examples, curing 36 examples (53.73%), produce effects 22 examples (32.84%), invalid 9 examples (13.43%), total effective rate is 86.57% matched group, 42 examples, cure 3 examples (7.14%), produce effects 16 examples (38.10%), invalid 13 examples (53.76%), 45.24%, two group of cure rate difference of total effective rate significance (ρ<0.05) is arranged.
4, brief summary
Clinical observation result shows, Litholysizing bear gall powder treatment cholelithiasis total effective rate is 86.57%, and cure rate is 53.73%, acts on really, evident in efficacy, obviously is better than the control drug cholagogic and lithagogue tablet.
Litholysizing bear gall powder serves as main the composition with Chinese herbal medicine, mineral medicine and animal drugs, has the effect of dispersing the stagnated live-QI to relieve the stagnation of QI, clearing heat secreting bile, nourishing the liver gallbladder cloudy blood, the stasis of blood of reducing phlegm, the molten hepatolith that disappears, full side's reasonable recipe, and compatibility is proper, thereby cholelithiasis is had the good curing effect.
Litholysizing bear gall powder is dosage form for oral administration, taking convenience, and no wound, no pain, clinical trial has no side effect, calculus dissolving and excreting rate height.
The specific embodiment 1:
Litholysizing bear gall powder of the present invention is made up of the raw material of following weight portion: Herba Lysimachiae 6, Herba Artemisiae Scopariae 15, Endothelium Corneum Gigeriae Galli 10, the Radix Paeoniae Alba 30, Fructus Lycii 10, Rhizoma Polygoni Cuspidati 10, the Radix Aucklandiae 10, Fructus Aurantii 6, Pericarpium Citri Reticulatae Viride 18, Pericarpium Citri Reticulatae 18, Rhizoma Cyperi 8, Radix Curcumae 20, Natrii Sulfas 15, Radix Et Rhizoma Rhei 10, Folium Pyrrosiae 30, Radix Glycyrrhizae 5, Radix Astragali 10, Radix Bupleuri 10, Radix Scutellariae 6, Pumex 15 Fructus Crataegi 13, Massa Medicata Fermentata 10, Fructus Hordei Germinatus 10, Radix Clematidis 30, Rhizoma Coptidis 5, Concha Margaritifera 25, the Radix Rehmanniae 15, Fel Ursi 8, Alumen 8.With above component levigation, 100 orders that sieve, encapsulatedly behind mixing, the disinfection by ultraviolet light all can.
The specific embodiment 2:
Litholysizing bear gall powder of the present invention is made up of the raw material of following weight portion: Herba Lysimachiae 180, Herba Artemisiae Scopariae 6, Endothelium Corneum Gigeriae Galli 10, the Radix Paeoniae Alba 30, Fructus Lycii 3, Rhizoma Polygoni Cuspidati 10, the Radix Aucklandiae 6, Fructus Aurantii 10, Pericarpium Citri Reticulatae Viride 30, Pericarpium Citri Reticulatae 10, Rhizoma Cyperi 10, Radix Curcumae 10 Natrii Sulfas 10, Radix Et Rhizoma Rhei 20, Folium Pyrrosiae 10, Radix Glycyrrhizae 5, Radix Astragali 10, Radix Bupleuri 6, Radix Scutellariae 10, Pumex 6 Fructus Crataegi 15, Massa Medicata Fermentata 6, Fructus Hordei Germinatus 15, Radix Clematidis 10, Rhizoma Coptidis 8, Concha Margaritifera 10, the Radix Rehmanniae 20, Fel Ursi 5, Alumen 10.With above component levigation, 100 orders that sieve, make powder behind mixing, the disinfection by ultraviolet light.
The specific embodiment 3:
Litholysizing bear gall powder of the present invention is made up of the raw material of following weight portion: Herba Lysimachiae 80, Herba Artemisiae Scopariae 9, Endothelium Corneum Gigeriae Galli 15, the Radix Paeoniae Alba 20, Fructus Lycii 6, Rhizoma Polygoni Cuspidati 18, the Radix Aucklandiae 6, Fructus Aurantii 8, Pericarpium Citri Reticulatae Viride 6, Pericarpium Citri Reticulatae 25, Rhizoma Cyperi 6, Radix Curcumae 30g Natrii Sulfas 13, Radix Et Rhizoma Rhei 15, Folium Pyrrosiae 20, Radix Glycyrrhizae 7, Radix Astragali 30, Radix Bupleuri 10, Radix Scutellariae 6, Pumex 15, Fructus Crataegi 10, Massa Medicata Fermentata 15, Fructus Hordei Germinatus 6, Radix Clematidis 60, Rhizoma Coptidis 3, Concha Margaritifera 40, the Radix Rehmanniae 10, Fel Ursi 15, Alumen 6.With above component levigation, 100 orders that sieve, make the watered pill behind mixing, the disinfection by ultraviolet light.
Claims (1)
1. powder for the treatment of liver and bile stone is characterized in that it is made up of the component of following weight portion: Herba Lysimachiae 6-180, Herba Artemisiae Scopariae 6-15, Endothelium Corneum Gigeriae Galli 10-20, Radix Paeoniae Alba 10-30, Fructus Lycii 3-10, Rhizoma Polygoni Cuspidati 10-25, Radix Aucklandiae 6-10, Fructus Aurantii 6-10, Pericarpium Citri Reticulatae Viride 6-30, Pericarpium Citri Reticulatae 10-25, Rhizoma Cyperi 6-10, Radix Curcumae 10-30 Natrii Sulfas 10-15, Radix Et Rhizoma Rhei 10-20, Folium Pyrrosiae 10-30, Radix Glycyrrhizae 5-10, Radix Astragali 10-30, Radix Bupleuri 6-10, Radix Scutellariae 6-10, Pumex 6-15, Fructus Crataegi 10-15, Massa Medicata Fermentata 6-15, Fructus Hordei Germinatus 6-15, Radix Clematidis 10-60, Rhizoma Coptidis 3-8, Concha Margaritifera 10-40, Radix Rehmanniae 10-20, Fel Ursi 5-15, Alumen 6-10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01128739A CN1130219C (en) | 2001-07-26 | 2001-07-26 | Litholysizing bear gall powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01128739A CN1130219C (en) | 2001-07-26 | 2001-07-26 | Litholysizing bear gall powder |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1334119A CN1334119A (en) | 2002-02-06 |
CN1130219C true CN1130219C (en) | 2003-12-10 |
Family
ID=4668573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN01128739A Expired - Fee Related CN1130219C (en) | 2001-07-26 | 2001-07-26 | Litholysizing bear gall powder |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1130219C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100340284C (en) * | 2005-08-03 | 2007-10-03 | 孙润古 | Jindan gallbladder stone dissolving capsule |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101143171B (en) * | 2007-08-29 | 2010-10-06 | 钱亚蒙 | Traditional Chinese medicine and its preparation method and its application |
CN103041288B (en) * | 2011-10-14 | 2015-12-02 | 湖南中医药大学 | A kind of Chinese medicine composition and preparation technology treating diabetic fatty liver |
CN102727837B (en) * | 2012-07-23 | 2014-04-16 | 鲁道宗 | Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis |
CN103566238B (en) * | 2012-07-24 | 2016-08-10 | 蔡义和 | The traditional Chinese medicine lithagogue pill for the treatment of calculus |
CN102861288B (en) * | 2012-09-04 | 2013-11-06 | 刘长灵 | Traditional Chinese medicine composite for treating kidney stone |
CN103041316B (en) * | 2013-01-15 | 2014-05-14 | 王天罡 | Traditional Chinese medicine for treating liver and gall lithiasis and method for preparing same |
CN105816804A (en) * | 2016-04-18 | 2016-08-03 | 陈中元 | Medicine for treating liver lithiasis and preparation thereof |
CN109224026A (en) * | 2017-07-10 | 2019-01-18 | 曾令元 | It is a kind of to treat cholelithiasis Chinese medicine composition and preparation method thereof |
CN108273011A (en) * | 2018-04-23 | 2018-07-13 | 唐山福珍全民生药店有限公司 | A kind of Chinese medicine preparation and preparation method thereof for treating cholecystitis and gall stone |
-
2001
- 2001-07-26 CN CN01128739A patent/CN1130219C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100340284C (en) * | 2005-08-03 | 2007-10-03 | 孙润古 | Jindan gallbladder stone dissolving capsule |
Also Published As
Publication number | Publication date |
---|---|
CN1334119A (en) | 2002-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1130219C (en) | Litholysizing bear gall powder | |
CN101164593A (en) | Oral liquid for treating kidney disease | |
CN1931329A (en) | Stomatocase treating medicine | |
CN1201803C (en) | Nasosinusitis treating Chinese medicine powder | |
CN101152453A (en) | Traditional Chinese medicine for treating chronic gingivitis | |
CN1739774A (en) | Spot eliminating and youthful looks preserving capsule | |
CN1404854A (en) | Medicine for treating nosal inflammation | |
CN100340284C (en) | Jindan gallbladder stone dissolving capsule | |
CN1136899C (en) | Chinese medicine for treating mastoplasia | |
CN1260209A (en) | Medicine for nephritis | |
CN1049598C (en) | Chinese medicine prepn for psoriasis and its prepn | |
CN1186044C (en) | Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis | |
CN1081464C (en) | Chinese medicine for acute and chronic diarrhea, dysentery with purulent and bloody stools, as well as acute and chronic colitis | |
CN1583073A (en) | Chinese patent medicinal prescription for catch-cold | |
CN1435227A (en) | Medicament for treating lumbar and cervical vertebra pain | |
CN1078905A (en) | A kind of medicine for external use for the treatment of hepatopathy | |
CN1616041A (en) | Chinese medicine composition for treating chronic ulcerative colitis | |
CN1146345A (en) | Quick-effect traditional Chinese medicine for curing difficult and complicated gynopathy | |
CN1063965C (en) | Chinese medicine 'Baoeryin' and its preparing process | |
CN1322558A (en) | an anti-cancer drug | |
CN1669571A (en) | Chinese traditional medicine for treating enteritis and appendicitis, and method for preparing same | |
CN101152300A (en) | Traditional Chinese medicine for treating stasis type intestinal obstruction | |
CN101966329A (en) | Medicament for treating rash | |
CN1745826A (en) | Chinese medicinal for treating heart disease | |
CN1228321A (en) | Drug for curing stone of urinary system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |